Lisata Therapeutics Stock Investor Sentiment

LSTA Stock  USD 2.76  0.06  2.13%   
About 61% of Lisata Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Lisata Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Lisata Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Lisata Therapeutics stock news signals to limit their universe of possible portfolio assets.
  

Lisata Therapeutics Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Lisata Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over a month ago at finance.yahoo.com         
March Biosciences Secures 28.4M Series A to Advance Therapy for T-Cell Lymphoma
Yahoo News
over a month ago at finance.yahoo.com         
Tyra Biosciences to Host Conference Call on Interim Clinical Data of TYRA-300 from SURF301 Phase 12 ...
Yahoo News
over a month ago at gurufocus.com         
RA Capital Management, L.P. Reduces Stake in Tyra Biosciences Inc
Gurufocus Stories at Macroaxis
over a month ago at finance.yahoo.com         
Harmony Biosciences Holdings, Inc. Earnings Expected to Grow Should You Buy?
Yahoo News
over a month ago at accesswire.com         
The Schall Law Firm Encourages Investor Participation In An Inquiry Into Pacific Biosciences of Cali...
news
over a month ago at zacks.com         
Castle Biosciences, Inc. is a Great Momentum Stock Should You Buy?
zacks News
over a month ago at simplywall.st         
Calculating The Intrinsic Value Of Tyra Biosciences, Inc.
Simply Wall St News at Macroaxis
over a month ago at seekingalpha.com         
Pacira Biosciences appoints Shawn Cross as CFO
seekingalpha News
over a month ago at prnewswire.com         
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635
prnewswire News
over a month ago at finance.yahoo.com         
Heres Why Were Not Too Worried About Cogent Biosciences Cash Burn Situation
Yahoo News
over a month ago at thelincolnianonline.com         
Aura Biosciences Price Target Raised to 24.00
news
over a month ago at prnewswire.com         
Alafair Biosciences CEO John Joyoprayitno Wins 2024 Austin Business Journals Best CEO Award
prnewswire News
over a month ago at finance.yahoo.com         
BofA Upgrades Tyra Biosciences As Investors Focus On Preclinical Data Amid High Benchmarks Set By Jo...
Yahoo News
over a month ago at benzinga.com         
Aura Biosciences Bladder Cancer Candidate Demonstrates Tumor Shrinkage In Patients With High-Grade D...
benzinga news
over a month ago at investors.com         
Stocks With Rising Relative Price Strength Harmony Biosciences
Investors Business Daily at Macroaxis
Far too much social signal, news, headlines, and media speculation about Lisata Therapeutics that are available to investors today. That information is available publicly through Lisata media outlets and privately through word of mouth or via Lisata internal channels. However, regardless of the origin, that massive amount of Lisata data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Lisata Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Lisata Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Lisata Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Lisata Therapeutics alpha.

Lisata Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Pacific Biosciences of California Advances While Market Declines Some Information for Investors
10/31/2024
2
Pacific Biosciences of California Inc Q3 2024 Earnings EPS Beats Estimates at -0. ...
11/07/2024
3
ARMISTICE CAPITAL, LLC Increases Stake in Aptose Biosciences Inc
11/15/2024
4
Alamar Biosciences Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinsons Research Through Development of Next Generation Biomarker As...
11/19/2024
5
Taconic Biosciences Announces New U.S. West Coast Production Location
11/20/2024
6
Parse Biosciences Partners with OMAPiX to Expand Access to Single Cell Sequencing
11/21/2024
7
Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
11/22/2024
8
Enveric Biosciences Preclinical Pharmacokinetic Studies of EB-003 Support Oral Bioavailability, ...
11/25/2024
9
Neurogene and Ventyx Biosciences rises after insider buying by executives
11/26/2024

Complementary Tools for Lisata Stock analysis

When running Lisata Therapeutics' price analysis, check to measure Lisata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lisata Therapeutics is operating at the current time. Most of Lisata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Lisata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lisata Therapeutics' price. Additionally, you may evaluate how the addition of Lisata Therapeutics to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Global Correlations
Find global opportunities by holding instruments from different markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device